BioDiscovery Releases Nexus Expression – A Fresh Approach to Gene Regulation Analysis
October 14, 2008
EL SEGUNDO, CA - BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of Nexus Expression for gene expression analysis. Nexus Expression uses a fresh new approach that provides users an intuitive yet powerful interface for using gene expression results to associate sample attributes with gene annotations and biological processes. “The design principal here has been the same as our very successful complementary product, Nexus Copy Number. We have created a software product that is computationally very powerful but at the same time has an uncluttered and intuitive user-interface making it extremely effortless to navigate and quick to get to biologically relevant information. Nexus Expression has been designed to make a researcher’s life easier by supporting all array platforms and generating results quickly with minimal effort.” said Dr. Soheil Shams, President of BioDiscovery, Inc.
Nexus Expression is a platform independent product and supports all array platforms including Affymetrix, Agilent, Illumina, Roche NimbleGen, and custom arrays. With single mouse clicks, the user can cluster genes and samples to discover expression patterns, simultaneously compare expression profiles of multiple comparisons alongside gene annotations, display significant genes in affected biological processes, perform enrichment analysis to identify genes that are significantly overrepresented in a population, and much more. With an intuitive interface and rich graphical and numerical outputs that are publication ready, Nexus Expression is an ideal product for those performing gene expression analysis.
About BioDiscovery, Inc.
BioDiscovery is a leader in the development of microarray advanced bioinformatics software and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology. Contact BioDiscovery: 310-414-8100 or www.biodiscovery.com